quinazolines has been researched along with Pituitary Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shlomo, A; Cooper, O | 1 |
| Bannykh, S; Ben-Shlomo, A; Bonert, V; Carmichael, J; Cook-Wiens, G; Cooper, O; Lim, S; Mamelak, A | 1 |
| Araki, T; Cooper, O; Fukuoka, H; Kano, M; Liu, X; Melmed, S; Tone, M; Tone, Y | 1 |
| Kim, EH; Kim, H; Lee, S; Park, Y; Suh, CO | 1 |
| Chen, H; Deng, J; Guo, G; Liu, Y; Peng, X; Tong, A; Wang, Y; Xu, J; You, C; Zhou, L | 1 |
| Donangelo, I; Gutman, S; Melmed, S; Ren, SG; Siegel, E; Vlotides, G | 1 |
| Heaney, AP | 1 |
| Jue, SF; Maurer, RA; Wang, YH | 1 |
2 review(s) available for quinazolines and Pituitary Neoplasms
| Article | Year |
|---|---|
Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside.
Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gefitinib; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Translational Research, Biomedical | 2017 |
Targeting pituitary tumors.
Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Drug Therapy, Combination; Humans; Ligands; Neoplasm Proteins; Pituitary Neoplasms; PPAR gamma; Quinazolines; Receptors, Estrogen; Receptors, Retinoic Acid; Securin | 2007 |
1 trial(s) available for quinazolines and Pituitary Neoplasms
| Article | Year |
|---|---|
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Lapatinib; Male; Middle Aged; Pilot Projects; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for quinazolines and Pituitary Neoplasms
| Article | Year |
|---|---|
ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice.
Topics: Animals; Antineoplastic Agents; Enhancer Elements, Genetic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Promoter Regions, Genetic; Quinazolines | 2015 |
Effective Treatment of Solitary Pituitary Metastasis with Panhypopituitarism in HER2-Positive Breast Cancer by Lapatinib.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Hypopituitarism; Lapatinib; Pituitary Neoplasms; Quinazolines; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2016 |
Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Topics: Adolescent; Adult; Aged; Annexin A2; Antineoplastic Agents; Brain; Cell Movement; Cell Proliferation; Child; Child, Preschool; Cohort Studies; Craniopharyngioma; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Oncogene Protein v-akt; Pituitary Neoplasms; Prognosis; Quinazolines; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands.
Topics: Animals; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA Primers; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Gene Expression; Immunoprecipitation; Ligands; Mice; Mice, Nude; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Quinazolines; Rats | 2008 |
Thyrotropin-releasing hormone stimulates phosphorylation of the epidermal growth factor receptor in GH3 pituitary cells.
Topics: Animals; Enzyme Inhibitors; ErbB Receptors; Genes, Reporter; Indoles; Luciferases; Maleimides; Mitogen-Activated Protein Kinases; Phosphorylation; Phosphotyrosine; Pituitary Neoplasms; Protein Kinase C; Quinazolines; Rats; Recombinant Proteins; Thyrotropin-Releasing Hormone; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tyrphostins | 2000 |